Dynamics of HSV-2 infection with a therapeutic vaccine

Herpes-Simplex Virus type 2 (HSV-2) is a lifelong infection, which has infected over 400 million individuals aged 15-49 years, worldwide. While the disease can be treated with episodic and suppressive antiviral drugs to reduce the rate of recurrence (i.e., symptomatic disease) and viral shedding, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Venturino, Ezio, Shoukat, Affan, Moghadas, Seyed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364041/
https://www.ncbi.nlm.nih.gov/pubmed/32695902
http://dx.doi.org/10.1016/j.heliyon.2020.e04368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364041/
https://www.ncbi.nlm.nih.gov/pubmed/32695902
http://dx.doi.org/10.1016/j.heliyon.2020.e04368

Ejemplares similares